Person profile
Public information reviewedJohn DeYoung
Board role
Director · Allogene Therapeutics, Inc. (NASDAQ: ALLO)
Allogene Therapeutics, Inc. (NASDAQ: ALLO)
Director · Current mandate
Director · Executive
- Public sources
- 2 reviewed
- Profile ownership
- Not yet claimed
- Last reviewed
- May 15, 2026

